S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
LON:POLX

Polarean Imaging (POLX) Share Forecast, Price & News

GBX 49
0.00 (0.00%)
(As of 05/13/2022 05:06 PM ET)
Add
Compare
Today's Range
48
50
50-Day Range
48.38
67
52-Week Range
35
113
Volume
230,807 shs
Average Volume
347,900 shs
Market Capitalization
£104.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive POLX News and Ratings via Email

Sign-up to receive the latest news and ratings for Polarean Imaging and its competitors with MarketBeat's FREE daily newsletter.

Polarean Imaging logo

About Polarean Imaging

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of polarized Xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
21
Year Founded
N/A

Sales & Book Value

Annual Sales
£1.35 million
Cash Flow
GBX 18.20 per share
Book Value
GBX 18.90 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£104.10 million
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Polarean Imaging (LON:POLX) Frequently Asked Questions

Who are Polarean Imaging's key executives?
Polarean Imaging's management team includes the following people:
  • Mr. Clairis Richard Hullihen, CEO & Director (Age 69, Pay $293.55k)
  • Dr. Bastiaan Driehuys Ph.D., Founder, CTO & Director (Age 53, Pay $50k)
  • Mr. Kenneth Paul West, Consultant & Non-Exec. Director (Age 65, Pay $123.93k)
  • Mr. Charles Fremont Osborne Jr., CFO & Director (Age 56)
  • Mr. Neil Wadehra, VP of Operations (Age 42)
  • Mr. Alex Dusek, Chief Commercial Officer (Age 55)
  • Mr. Stephen Austin, Company Sec.
What other stocks do shareholders of Polarean Imaging own?
What is Polarean Imaging's stock symbol?

Polarean Imaging trades on the London Stock Exchange (LON) under the ticker symbol "POLX."

How do I buy shares of Polarean Imaging?

Shares of POLX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Polarean Imaging's stock price today?

One share of POLX stock can currently be purchased for approximately GBX 49.

How much money does Polarean Imaging make?

Polarean Imaging has a market capitalization of £104.10 million and generates £1.35 million in revenue each year.

How many employees does Polarean Imaging have?

Polarean Imaging employs 21 workers across the globe.

What is Polarean Imaging's official website?

The official website for Polarean Imaging is www.polarean.com.

How can I contact Polarean Imaging?

The company can be reached via phone at 919 206 7900.

This page was last updated on 5/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.